Pacific Biosciences of California | 10-Q: Quarterly report

SEC announcement06:08 ET · Announcements

Peering Into Pacific Biosciences's Recent Short Interest

BenzingaAug 8 11:30 ET

PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y

Zacks Aug 8 11:15 ET

Cantor Fitzgerald Reiterates Overweight on Pacific Biosciences, Maintains $3.5 Price Target

Analyst UpgradesAug 8 10:42 ET

Piper Sandler Keeps Their Hold Rating on Pacific Biosciences (PACB)

TipRanksAug 8 08:18 ET · Ratings

Pacific Biosciences Is Maintained at Buy by Canaccord Genuity

Dow JonesAug 8 06:56 ET